Trial · NCT04251273
Text Message Quit Vaping Intervention for Young Adults
NCT04251273, Not applicable, Completed, Truth Initiative; results first posted 2023-02-14
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Text Message Quit Vaping Intervention for Young Adults. Trials, record NCT04251273. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04251273
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Text Message Quit Vaping Intervention for Young Adults
- NCT number
- NCT04251273
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 2,588 participants, actual
- Lead sponsor
- Truth Initiative
- Conditions
- Tobacco Cessation
- Interventions
- This is Quitting, Assessment only Control
- First posted
- 2020-01-31
- Last updated
- 2024-07-10
- Results first posted
- 2023-02-14
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Participants With Self-reported 30-day Point Prevalence Abstinence (ITT) | 7 months post enrollment | Number of participant who responded "No" to the question "In the past 30 days, did you vape at all, even a puff of someone else's?" Denominator is all randomized participants. |
| Secondary | Number of Participants With Self-reported 30-day Point Prevalence Abstinence (Responder Only) | 7 month post enrollment | Number of participants with who responded 'No" to the question "In the past 30 days, did you vape at all, even a puff of someone else's?" Denominator is participants with responses only. |
| Secondary | Number of Participants With Self-reported 7-day Point Prevalence Abstinence (ITT) | 7 months post enrollment | Number of participants who responded "No" to the question "Have you used any vape, even one puff, in the past 7 days?" Denominator is all randomized participants. |
| Secondary | Number of Participants With Self-reported 7-day Point Prevalence Abstinence (Responder Only) | 7 months post enrollment | Number of participants who responded "No" to the question "Have you used any vape, even one puff, in the past 7 days?" Denominator is those who responded to the question only. |
Source ClinicalTrials.gov
Outcomes4
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants With Self-reported 30-day Point Prevalence Abstinence (ITT) | 7 months post enrollment | All randomized participants (Intent-to-treat analysis) | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With Self-reported 30-day Point Prevalence Abstinence (Responder Only) | 7 month post enrollment | 7 month assessment responders only (Responder Only) | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With Self-reported 7-day Point Prevalence Abstinence (ITT) | 7 months post enrollment | All randomized participants (intent-to-treat analysis) | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With Self-reported 7-day Point Prevalence Abstinence (Responder Only) | 7 months post enrollment | Only 7-month survey responders (responder only analysis) | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group8
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Self-reported 30-day Point Prevalence Abstinence (ITT) | This is Quitting | 314 | Participants | ||
| Number of Participants With Self-reported 30-day Point Prevalence Abstinence (ITT) | Assessment Only Control | 239 | Participants | ||
| Number of Participants With Self-reported 30-day Point Prevalence Abstinence (Responder Only) | This is Quitting | 314 | Participants | ||
| Number of Participants With Self-reported 30-day Point Prevalence Abstinence (Responder Only) | Assessment Only Control | 239 | Participants | ||
| Number of Participants With Self-reported 7-day Point Prevalence Abstinence (ITT) | This is Quitting | 440 | Participants | ||
| Number of Participants With Self-reported 7-day Point Prevalence Abstinence (ITT) | Assessment Only Control | 385 | Participants | ||
| Number of Participants With Self-reported 7-day Point Prevalence Abstinence (Responder Only) | This is Quitting | 440 | Participants | ||
| Number of Participants With Self-reported 7-day Point Prevalence Abstinence (Responder Only) | Assessment Only Control | 385 | Participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | This is Quitting | 1,304 | |
| Overall Study | STARTED | Assessment Only Control | 1,284 | |
| Overall Study | COMPLETED | This is Quitting | 973 | |
| Overall Study | COMPLETED | Assessment Only Control | 994 | |
| Overall Study | NOT COMPLETED | This is Quitting | 331 | |
| Overall Study | NOT COMPLETED | Assessment Only Control | 290 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | This is Quitting | 0 | 1,304 |
| Total, all-cause mortality | Assessment Only Control | 0 | 1,284 |
| Total, other adverse events | This is Quitting | 0 | 1,304 |
| Total, other adverse events | Assessment Only Control | 0 | 1,284 |
| Total, serious adverse events | This is Quitting | 0 | 1,304 |
| Total, serious adverse events | Assessment Only Control | 0 | 1,284 |
Source ClinicalTrials.gov
Papers4
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons6
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| This is Quitting vs Assessment Only Control: Number of Participants With Self-reported 7-day Point Prevalence Abstinence (Responder Only) | Trial comparisons |
| This is Quitting vs Assessment Only Control: Number of Participants With Self-reported 30-day Point Prevalence Abstinence (Responder Only) | Trial comparisons |
| This is Quitting vs Assessment Only Control: Number of Participants With Self-reported 30-day Point Prevalence Abstinence (ITT) | Trial comparisons |
| This is Quitting vs Assessment Only Control: deaths from any cause | Trial comparisons |
| This is Quitting vs Assessment Only Control: Number of Participants With Self-reported 7-day Point Prevalence Abstinence (ITT) | Trial comparisons |
| This is Quitting vs Assessment Only Control: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04251273
GET https://conductscience.org/api/trials/v1/NCT04251273/registered